Recombinant Human LIF Protein

Carrier Free

Catalog # Availability Size / Price Qty
7734-LF-025/CF
7734-LF-100/CF
7734-LF-500/CF

With Carrier

Catalog # Availability Size / Price Qty
7734-LF-025
7734-LF-100
7734-LF-500
Best Seller
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (30)
FAQs
Reviews (3)

Recombinant Human LIF Protein Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
Activity
Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED 50 for this effect is 0.02-0.12 ng/mL.
Source
E. coli-derived human LIF protein Pro24-Phe202
Accession #
N-terminal Sequence
Analysis
Pro24
Predicted Molecular Mass
19.6 kDa
SDS-PAGE
19 kDa, reducing conditions

Product Datasheets

You must select a language.

x

7734-LF (with carrier)

You must select a language.

x

7734-LF/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

7734-LF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 3 months, -20 to -70 degreesC under sterile conditions after reconstitution.

7734-LF/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 3 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: LIF

LIF (leukemia inhibitory factor) is a widely expressed, highly and variably glycosylated, 32-62 kDa, monomeric, pleiotropic cytokine in the IL-6 family of helical cytokines (1-4). The first exon encoding the signal sequence is alternately spliced, resulting in LIF-D, LIF-M, and LIF-T mRNAs that produce secreted, extracellular matrix-associated, and intracellular forms, respectively (5). LIF-D and LIF-M mRNAs produce identical 180 amino acid (aa) mature sequences (5). Mature human LIF (180 aa) shares 78%, 82%, 91%, 88 and 87% aa sequence identity with mouse, rat, canine, bovine, and porcine LIF, respectively. The LIF receptor is a heterodimer of a type I transmembrane ligand-binding subunit, LIFR (gp190), and the type I transmembrane signal transducing subunit, gp130, signaling especially through STAT3 and JAK kinases (3, 4, 6). Gp130 and members of the LIFR family also mediate the biological effects of Oncostatin M, Cardiotrophin-1, Galectin-10, CNTF, IL-6, IL-11, and IL-27 (3, 6). A soluble LIFR has been reported in the mouse (7). Depending on the cells and their context, LIF either opposes or favors differentiation (3, 8). LIF produced by the uterine endometrium supports successful implantation of the embryo, promotes proliferation and maintenance of pluripotency in embryonic stem cells, and favors proliferation of progenitor cell types such as hematopoietic stem cells (3, 6, 8). However, excess LIF blocks differentiation of embryoid bodies, indicating the importance of LIF regulation (3, 6). LIF is produced by CD4 + T cells in response to activation, and is required by the thymic epithelium to support T cell maturation (3, 4). LIF expression is up-regulated by neuronal injury, and promotes motor neuron survival and oligodendrocyte myelination (3, 4, 9). LIF is produced by the adrenal cortex and likely enhances its production of cortisol and aldosterone (10). LIF can function as an autocrine growth factor in some pancreatic cancers, but induces differentiation in the myeloid leukemic cell line M1 (2, 11). Tumor LIF can also induce formation of immunosuppressive tumor-associated macrophages (12). LIF promotes endometrial remodeling and differentiation of adipocytes and cardiac smooth muscle cells (3, 4). It promotes regulatory T cell and inhibits Th17 cell differentiation, thus promoting tolerance, down-regulating inflammation, and contributing to immune tolerance during pregnancy and in the nervous system (3, 4, 6, 8).

References
  1. Gough, N.M. et al. (1988) Proc. Natl. Acad. Sci. USA 85:2623.
  2. Moreau, J.F. et al. (1988) Nature 336:690.
  3. Trouillas, M. et al. (2009) Eur. Cytokine Netw. 20:51.
  4. Metcalfe, S.M. (2011) Genes Immun. 12:157.
  5. Voyle, R.B. et al. (1999) Exp. Cell Res. 249:199.
  6. Cheng, J.G. et al. (2001) Proc. Natl. Acad. Sci. USA 98:8680.
  7. Tomida, M. et al. (1993) FEBS lett. 334:193.
  8. Paiva, P. et al. (2009) Cytokine Growth Factor Rev. 20:319.
  9. Slaets, H. et al. (2010) Trends Mol. Med. 16:493.
  10. Bamberger, A.M. et al. (2000) Mol. Cell. Endocrinol. 162:145.
  11. Kamohara, H. et al. (2007) Int. J. Oncol. 30:977.
  12. Duluc, D. et al. (2007) Blood 110:4319.
Long Name
Leukemia Inhibitory Factor
Entrez Gene IDs
3976 (Human); 16878 (Mouse); 403449 (Canine)
Alternate Names
CDF; D Factor; DIA; differentiation inhibitory activity; differentiation stimulating factor; Differentiation-stimulating factor; Emfilermin; HILDA; HILDAcholinergic differentiation factor; leukemia inhibitory factor (cholinergic differentiation factor); leukemia inhibitory factor; LIF; Melanoma-derived LPL inhibitor; MLPLI

Citations for Recombinant Human LIF Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

30 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Engineered Interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMR
    Authors: Rafii, P;Cruz, PR;Ettich, J;Seibel, C;Padrini, G;Wittich, C;Lang, A;Petzsch, P;Köhrer, K;Moll, JM;Floss, DM;Scheller, J;
    The Journal of biological chemistry
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  2. TGF-?-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer
    Authors: Zhang, F;Yan, Y;Cao, X;Guo, C;Wang, K;Lv, S;
    Cell death & disease
    Species: Human hepegivirus
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130
    Authors: Widjaja, AA;Cook, SA;
    International journal of molecular sciences
  4. Cynomolgus monkey embryo model captures gastrulation and early pregnancy
    Authors: J Li, Q Zhu, J Cao, Y Liu, Y Lu, Y Sun, Q Li, Y Huang, S Shang, X Bian, C Li, L Zhang, Y Wang, Y Nie, J Fu, W Li, MA Mazid, Y Jiang, W Jia, X Wang, Y Sun, MA Esteban, Q Sun, F Zhou, Z Liu
    Cell Stem Cell, 2023-04-06;30(4):362-377.e7.
    Species: Primate - Macaca fascicularis (Crab-eating Monkey or Cynomolgus Macaque)
    Sample Types: Whole Cells
    Applications: Bioassay
  5. Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis
    Authors: S Xu, X Yang, Q Chen, Z Liu, Y Chen, X Yao, A Xiao, J Tian, L Xie, M Zhou, Z Hu, F Zhu, X Xu, F Hou, J Nie
    EBioMedicine, 2022-11-04;86(0):104312.
    Species: Mouse, Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  6. The balance between NANOG and SOX17 mediated by TET proteins regulates specification of human primordial germ cell fate
    Authors: Z Li, F Fang, Y Long, Q Zhao, X Wang, Z Ye, T Meng, X Gu, W Xiang, C Xiong, H Li
    Cell & bioscience, 2022-11-04;12(1):181.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  7. CoSpar identifies early cell fate biases from single-cell transcriptomic and lineage information
    Authors: SW Wang, MJ Herriges, K Hurley, DN Kotton, AM Klein
    Nature Biotechnology, 2022-02-21;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  8. Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells
    Authors: M Lindkvist, MM Zegeye, M Grenegård, LU Ljungberg
    International Journal of Molecular Sciences, 2022-01-27;23(3):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  9. PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer
    Authors: YC Wen, CL Liu, HL Yeh, WH Chen, KC Jiang, VTN Tram, M Hsiao, J Huang, WY Chen, YN Liu
    British Journal of Cancer, 2021-11-24;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Generation of human blastocyst-like structures from pluripotent stem cells
    Authors: Y Fan, Z Min, S Alsolami, Z Ma, E Zhang, W Chen, K Zhong, W Pei, X Kang, P Zhang, Y Wang, Y Zhang, L Zhan, H Zhu, C An, R Li, J Qiao, T Tan, M Li, Y Yu
    Cell Discovery, 2021-09-07;7(1):81.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway
    Authors: H Wang, S Si, M Jiang, L Chen, K Huang, W Yu
    Oncology Letters, 2021-07-14;22(3):663.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  12. HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
    Authors: ME Clements, L Holtslande, C Edwards, V Todd, SDR Dooyema, K Bullock, K Bergdorf, CA Zahnow, RM Connolly, RW Johnson
    Oncogene, 2021-07-10;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  13. The histone demethylase KDM2B regulates human primordial germ cell-like cells specification
    Authors: W Yuan, Z Yao, V Veerapandi, X Yang, X Wang, D Chen, L Ma, C Li, Y Zheng, F Luo, XY Zhao
    International journal of biological sciences, 2021-01-01;17(2):527-538.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  14. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer
    Authors: SR Lin, YC Wen, HL Yeh, KC Jiang, WH Chen, N Mokgautsi, J Huang, WY Chen, YN Liu
    Oncogene, 2020-09-22;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  15. Analysis of multi-lineage gene expression dynamics during primordial germ cell induction from human induced pluripotent stem cells
    Authors: F Fang, Z Li, Q Zhao, C Xiong, K Ni
    Stem Cell Res Ther, 2020-03-04;11(1):100.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  16. Supplementation of vitamin C promotes early germ cell specification from human embryonic stem cells
    Authors: Z Li, F Fang, Q Zhao, H Li, C Xiong
    Stem Cell Res Ther, 2019-11-15;10(1):324.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  17. EC359-A first-in-class small molecule inhibitor for targeting oncogenic LIFR signaling in triple negative breast cancer
    Authors: S Viswanadha, Y Luo, GR Sareddy, B Santhamma, M Zhou, M Li, S Ma, R Sonavane, UP Pratap, KA Altwegg, X Li, A Chang, AC Riveros, KV Dileep, KYJ Zhang, X Pan, R Murali, M Bajda, GV Raj, AJ Brenner, V Manthati, MK Rao, RR Tekmal, HB Nair, KJ Nickisch, RK Vadlamudi
    Mol. Cancer Ther., 2019-05-29;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Surface Plasmon Resonance
  18. STAT3 signaling stimulates miR-21 expression in bovine cumulus cells during in vitro oocyte maturation
    Authors: A Tscherner, AC Brown, L Stalker, J Kao, I Dufort, MA Sirard, J LaMarre
    Sci Rep, 2018-08-01;8(1):11527.
    Species: Bovine
    Sample Types: Whole Cells
    Applications: Bioassay
  19. The transcription factor Vezf1 represses the expression of the antiangiogenic factor d2 in endothelial cells
    Authors: L Alabdi, M He, Q Yang, AB Norvil, H Gowher
    J. Biol. Chem., 2018-05-24;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  20. LIFR increases the release of sEng via the up-regulation of MMP14 expression in PE
    Authors: H Li, J Yao, X Chang, J Wu, T Duan, K Wang
    Reproduction, 2018-01-23;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  21. miR-124 promotes proliferation and differentiation of neuronal stem cells through inactivating Notch pathway
    Authors: S Jiao, Y Liu, Y Yao, J Teng
    Cell Biosci, 2017-12-11;7(0):68.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  22. Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke
    Authors: H Zhang, F Sun, J Wang, L Xie, C Yang, M Pan, B Shao, GY Yang, SH Yang, Q ZhuGe, K Jin
    Aging Dis, 2017-04-01;8(2):203-214.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  23. Increased susceptibility to a? toxicity in neuronal cultures derived from familial Azheimer's disease (PSEN1-A246E) induced pluripotent stem cells
    Authors: Enrique Armijo
    Neurosci. Lett, 2016-12-26;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  24. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
    Nat Cell Biol, 2016-09-19;18(10):1078-1089.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  25. A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor beta Subunit, Glycoprotein 130.
    Authors: Hong S, Choi J, Lee S, Park Y, Park K, Lee J, Kim J, Gajulapati V, Goo J, Singh S, Lee K, Kim Y, Im S, Ahn S, Rose-John S, Heo T, Choi Y
    J Immunol, 2015-05-29;195(1):237-45.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  26. Targeted Knockdown of RNA-Binding Protein TIAR for Promoting Self-Renewal and Attenuating Differentiation of Mouse Embryonic Stem Cells.
    Authors: Geng, Zhe, Li, Ping, Tan, Li, Song, Houyan
    Stem Cells Int, 2015-03-31;2015(0):657325.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  27. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Authors: Kwofie K, Scott M, Rodrigues R, Guerette J, Radford K, Nair P, Richards C
    Respir Res, 2015-02-07;16(0):14.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  28. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.
    Authors: Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P, Vandesompele J, Vanhove C, Maynard D, Lehuede C, Muller C, Valet P, Gespach C, Bracke M, Cocquyt V, Denys H, De Wever O
    Cancer Res, 2014-09-24;74(23):6806-19.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  29. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice.
    Authors: Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M, Takahashi R, Okano H, Yamanaka S, Inoue H
    Stem Cell Reports, 2014-06-26;3(2):242-9.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  30. The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).
    Authors: Wagener E, Aurich M, Aparicio-Siegmund S, Floss D, Garbers C, Breusing K, Rabe B, Schwanbeck R, Grotzinger J, Rose-John S, Scheller J
    J Biol Chem, 2014-05-06;289(26):18442-50.
    Species: Human, Mouse
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human LIF Protein

Average Rating: 4.3 (Based on 3 Reviews)

5 Star
66.67%
4 Star
0%
3 Star
33.33%
2 Star
0%
1 Star
0%

Have you used Recombinant Human LIF Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human LIF Protein
By Anonymous on 04/17/2020
Application: Apoptosis assay

Recombinant Human LIF Protein
By Anonymous on 04/09/2017
Application: Cell migration/motility

Growth of MA-11 spheroids in serum-free condition in the absence (A) or presence (B) of Recombinant Human LIF (#7734-LF) after 72 hours. Medium: RPMI + 2% B-27 supplement + 1% L-glutamine + 1% Pen/Strep.


Recombinant Human LIF Protein
By Anonymous on 08/03/2016
Application: Stem/Immune cell maintenance or differentiation